{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:12:36Z","timestamp":1794471156529,"version":"4.9.1"},"reference-count":37,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CoDAS"],"abstract":"<jats:p>Abstract Purpose Investigate the association between levodopa therapy and vocal characteristics in Parkinson\u2019s disease patients. Search strategy Studies published at MEDLINE, LILACS, and SciELO, from 1960 to December 2016. A systematic review and meta-analysis was performed using the following keywords: Parkinson\u2019s disease; levodopa; L-dopa; voice; speech disorders; dysphonia; dysarthria. After analyzing titles and abstracts, two independent reviewers selected all clinical trials that met the eligibility criteria and selected the articles and the data recorded in a previously standardized table. Selection criteria Trials published in English between 1960 and December 2016 individuals with clinical diagnosis of Parkinson\u2019s disease; use of levodopa therapy in stable doses; acoustic analysis combined or not with auditory-perceptual analysis to evaluate the vocal parameters under investigation. Data analysis The following vocal parameters were analyzed: fundamental frequency (F 0), jitter, and vocal intensity. Standardized mean differences (SMD) were calculated using the Comprehensive Meta-analysis V2 software. Results Nine articles met the eligibility criteria and were selected, with a total of 119 individuals. From these, six articles with 83 individuals were included in the meta-analysis. During the levodopa therapy \u201con\u201d state, modifications in F 0 (SMD=0.39; 95% CI - 0.21-0.57) and jitter (SMD=0.23; 95% CI - 0.02-0.45) were observed. Vocal intensity was not affected (SMD=0.09; 95% CI - 0.22-0.39) by levodopa ingestion. Data of the included studies were controversial in the auditory-perceptual analysis of voice. Conclusion Levodopa therapy modifies F0 and jitter. No changes in vocal intensity were observed in either the \u201con\u201d or \u201coff\u201d states of levodopa therapy.<\/jats:p>","DOI":"10.1590\/2317-1782\/20182017200","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T19:55:25Z","timestamp":1538596525000},"source":"Crossref","is-referenced-by-count":35,"title":["Impact of levodopa treatment in the voice pattern of Parkinson\u2019s disease patients: a systematic review and meta-analysis"],"prefix":"10.1590","volume":"30","author":[{"given":"Patr\u00edcia","family":"Pinho","sequence":"first","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francisca de Paula","family":"Soares","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil; Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Tourinho","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailton","family":"Melo","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Caline","family":"N\u00f3brega","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil; Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"issue":"1-2","key":"ref1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jns.2007.08.015","article-title":"Management of non-motor symptoms in advanced Parkinson disease","volume":"266","author":"Truong DD","year":"2008","journal-title":"J Neurol Sci"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-1331.2011.03402.x","article-title":"Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson\u2019s disease: preliminary analysis from the French COPARK cohort","volume":"19","author":"Perez Lloret S","year":"2012","journal-title":"Eur J Neurol"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000348940411300401","article-title":"Laringeal findings in advanced Parkinson\u2019s disease","volume":"113","author":"Blumin JH","year":"2004","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MOO.0b013e3282febd3a","article-title":"Speech and swallowing disorders in Parkinson disease","volume":"16","author":"Sapir S","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ageing\/afj053","article-title":"Life with communication changes in Parkinson\u2019s disease","volume":"35","author":"Miller N","year":"2006","journal-title":"Age Ageing"},{"key":"ref6","first-page":"1","article-title":"New aspects of pathology in Parkinson\u2019s disease with concomitant incipient Alzheimer\u2019s disease","volume":"48","author":"Braak H","year":"1996","journal-title":"J Neural Transm Suppl"},{"key":"ref7","series-title":"M\u00e9todos de avalia\u00e7\u00e3o e diagn\u00f3stico de laringe e voz.","first-page":"145","volume-title":"Doen\u00e7as neurol\u00f3gicas \u2013 repercuss\u00f5es lar\u00edngeas e vocais.","author":"Cervantes O","year":"2002"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak H","year":"2003","journal-title":"Neurobiol Aging"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"s121","DOI":"10.1007\/s100720200099","article-title":"Clinical assessment of dysphagia in early phases of Parkinson\u2019s disease","volume":"23","author":"Volont\u00e9 MA","year":"2002","journal-title":"Neurol Sci"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/14737175.8.2.297","article-title":"Speech treatment for Parkinson disease","volume":"8","author":"Ramig L","year":"2008","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0021-9924(75)90019-2","article-title":"Speech changes in Parkinson\u2019s disease during treatment with L-dopa","volume":"8","author":"Wolfe VI","year":"1975","journal-title":"J Commun Disord"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bandl.2005.01.008","article-title":"Speech motor programming in hypokinetic and ataxic dysarthria","volume":"94","author":"Spencer KA","year":"2005","journal-title":"Brain Lang"},{"issue":"22-23","key":"ref13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jvoice.2006.10.010","article-title":"Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment","author":"D'Alatri L","year":"2008","journal-title":"J Voice"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (MINORS): development and validation of a new instrument","volume":"73","author":"Slim K","year":"2003","journal-title":"ANZ J Surg"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00005537-199908000-00019","article-title":"Glottographic measures before and after levodopa treatment in Parkinson\u2019s disease","volume":"109","author":"Jiang J","year":"1999","journal-title":"Laryngoscope"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00002826-200103000-00006","article-title":"The effect of levodopa on vocal function in Parkinson\u2019s disease","volume":"2","author":"Sanabria J","year":"2001","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-9924(01)00072-7","article-title":"Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states","volume":"35","author":"Goberman A","year":"2002","journal-title":"J Commun Disord"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/02699200701538181","article-title":"Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson\u2019s disease as perceived by professional listeners","volume":"21","author":"De Letter M","year":"2007","journal-title":"Clin Linguist Phon"},{"issue":"4","key":"ref19","first-page":"574","article-title":"For better or worse: the effect of levodopa on speech in Parkinson\u2019s disease","volume":"4","author":"Ho AK","year":"2008","journal-title":"Mov Disord"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/NRE-2009-0462","article-title":"Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems","volume":"24","author":"Plowman-Prine EK","year":"2009","journal-title":"NeuroRehabilitation"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/17549507.2010.491556","article-title":"Sequential changes in motor speech acroos a levodopa cycle in advanced Parkinson\u2019s disease","volume":"12","author":"Letter M","year":"2010","journal-title":"Int J Speech-Language Pathol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-009-0351-5","article-title":"Short- and long-term dopaminergic effects on dysarthria in early Parkinson\u2019s disease","volume":"117","author":"Skodda S","year":"2010","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1590\/0004-282X20130141","article-title":"Prosody and levodopa in Parkinson\u2019s disease","volume":"71","author":"Azevedo LL","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.clinthera.2012.03.001","article-title":"The effect of levodopa on pulmonary funcion in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"34","author":"Monteiro L","year":"2012","journal-title":"Clin Ther"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1044\/1092-4388(2001\/100)","article-title":"Effects of Levodopa on layngeal muscle activity for voice onset and offset in Parkinson disease","volume":"44","author":"Gallena S","year":"2011","journal-title":"J Speech Lang Hear Res"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1123\/mcj.2.2.161","article-title":"Effect of oral levodopa treatment on articulatory function in Parkinson\u2019s disease: preliminary results","volume":"2","author":"Cahill LM","year":"1998","journal-title":"Mot Contr"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000008087","article-title":"Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson\u2019s disease","volume":"42","author":"Gentil M","year":"1999","journal-title":"Eur Neurol"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.34.6.679","article-title":"Effect of L-dopa on speech in Parkinsonism. An EMG study of labial articulatory function","volume":"34","author":"Leanderson R","year":"1971","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"ref29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2174\/0929867023369808","article-title":"The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson\u2019s disease: a review of the literature","volume":"9","author":"Schulz G","year":"2009","journal-title":"Curr Med Chem"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.parkreldis.2010.07.004","article-title":"Respiratory problems in neurologic movement disorders","volume":"16","author":"Mehanna R","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.10072","article-title":"Disordered respiration as a levodopa-induced dyskinesia in Parkinson\u2019s Disease","volume":"17","author":"Rice JE","year":"2002","journal-title":"Mov Disord"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0892-1997(05)80130-4","article-title":"Perceptual evaluation","volume":"6","author":"Fex S","year":"1992","journal-title":"J Voice"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0892-1997(05)80132-8","article-title":"On terminology of voice research","volume":"6","author":"Sonninen A","year":"1992","journal-title":"J Voice"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00005053-196405000-00002","article-title":"A critical analysis of the effects of trihexyphenidyl (artane) on the components of the parkinsonian syndrome","volume":"138","author":"Brumuk J","year":"1964","journal-title":"J Nerv Ment Dis"},{"issue":"13","key":"ref35","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jama.1971.03190260028007","article-title":"Absorption and metabolism of Levodopa","volume":"218","author":"Abrams WB","year":"1971","journal-title":"JAMA"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/WNL.54.2.458","article-title":"Effects of central dopaminergic stimulation by apomorphine on vocal parameters in parkinson\u2019s disease","volume":"54","author":"Kompoliti K","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp.52.2.201","article-title":"Does cognitive impairment in Parkinson\u2019s disease result from non-dopaminergic lesions?","volume":"52","author":"Pillon B","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["CoDAS"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/codas\/v30n5\/2317-1782-codas-30-5-e20170200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:03:33Z","timestamp":1605139413000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2317-17822018000500602&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018]]}},"alternative-id":["S2317-17822018000500602"],"URL":"https:\/\/doi.org\/10.1590\/2317-1782\/20182017200","relation":{},"ISSN":["2317-1782"],"issn-type":[{"value":"2317-1782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]}}}